当前位置:首页 - 行情中心 - 成大生物(688739) - 财务分析 - 现金流量表

成大生物

(688739)

  

流通市值:54.39亿  总市值:119.98亿
流通股本:1.89亿   总股本:4.16亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金353,763,410.471,818,432,008.191,254,158,851.29817,265,656.56
收到的税费返还381,952.04757,937.59463,243.94348,091.72
收到其他与经营活动有关的现金15,654,489.8777,201,443.5260,049,159.5141,807,278.64
经营活动现金流入的平衡项目0000
经营活动现金流入小计369,799,852.381,896,391,389.31,314,671,254.74859,421,026.92
购买商品、接受劳务支付的现金80,887,065.04248,868,748.92156,639,994.5699,209,701.51
支付给职工以及为职工支付的现金134,655,563.58333,082,881.29264,452,783.18192,312,913.16
支付的各项税费32,036,809.66182,844,938.36133,715,818.9386,059,546.57
支付其他与经营活动有关的现金88,967,728.37454,586,883.68317,393,148.92196,878,408.62
经营活动现金流出的平衡项目0000
经营活动现金流出小计336,547,166.651,219,383,452.25872,201,745.59574,460,569.86
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额33,252,685.73677,007,937.05442,469,509.15284,960,457.06
二、投资活动产生的现金流量:
收回投资收到的现金672,073,747.095,453,802,241.853,528,773,885.611,634,461,963.75
取得投资收益收到的现金3,720,475.6133,275,063.9422,363,263.59,806,143.33
处置固定资产、无形资产和其他长期资产收回的现金净额6,058,00019,611.6519,611.6519,611.65
投资活动现金流入的平衡项目0000
投资活动现金流入小计681,852,222.75,487,096,917.443,551,156,760.761,644,287,718.73
购建固定资产、无形资产和其他长期资产支付的现金94,645,469.52551,989,885.2461,299,609.97289,151,972.4
投资支付的现金560,000,0006,337,000,0004,875,000,0003,005,000,000
支付其他与投资活动有关的现金21,557.49390,323.7555,123.0846,517.85
投资活动现金流出的平衡项目0000
投资活动现金流出小计654,667,027.016,889,380,208.955,336,354,733.053,294,198,490.25
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额27,185,195.69-1,402,283,291.51-1,785,197,972.29-1,649,910,771.52
三、筹资活动产生的现金流量:
分配股利、利润或偿付利息支付的现金-416,321,900416,299,100416,299,100
支付其他与筹资活动有关的现金17,577,468.25106,368,889.9628,834,336.183,421,380.99
筹资活动现金流出平衡项目0000
筹资活动现金流出小计17,577,468.25522,690,789.96445,133,436.18419,720,480.99
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-17,577,468.25-522,690,789.96-445,133,436.18-419,720,480.99
四、汇率变动对现金及现金等价物的影响41,736.172,290,411.041,429,541.911,348,305.28
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额42,902,149.34-1,245,675,733.38-1,786,432,357.41-1,783,322,490.17
加:期初现金及现金等价物余额4,544,605,341.535,790,281,074.915,790,281,074.915,790,281,074.91
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额4,587,507,490.874,544,605,341.534,003,848,717.54,006,958,584.74
补充资料:
净利润-465,923,566.68-333,611,527.78
资产减值准备-109,805,229.7-13,943,068.39
固定资产和投资性房地产折旧-114,224,928.66-53,405,653.96
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-114,224,928.66-53,405,653.96
无形资产摊销-6,010,767.82-2,934,170.67
长期待摊费用摊销-3,705,193.75-1,846,404.48
处置固定资产、无形资产和其他长期资产的损失--2,482,317.43--8,811.65
固定资产报废损失-871,276.13-173,198.4
公允价值变动损失--8,102,948.8--5,231,449.39
财务费用--1,296,997.21--838,482.85
投资损失--25,022,730.62--13,009,174.06
递延所得税--7,214,455.19--7,908,305.42
其中:递延所得税资产减少--10,935,150.24--9,141,383.06
递延所得税负债增加-3,720,695.05-1,233,077.64
存货的减少-419,833.16-7,649,442.32
经营性应收项目的减少-13,823,094.37--87,874,802.54
经营性应付项目的增加--11,838,363.55--26,699,900.84
其他-62,011.75-38,771.85
现金的期末余额-4,544,605,341.53-4,006,958,584.74
减:现金的期初余额-5,790,281,074.91-5,790,281,074.91
公告日期2024-04-302024-04-232023-10-272023-08-30
审计意见(境内)标准无保留意见
TOP↑